The Doctors Company Announces $7.3 Million Member Dividend
The Doctors Company announced today that it has approved a 2022 premium dividend of approximately $7.3 million, bringing the total of declared dividends to date to more than $446 million.
Search
Professional Education
Prevention of Medical Errors 2024 to 2026 (Florida)
Few medical errors are attributed to faulty medical judgment. More commonly, they are attributed to system failures inherent in healthcare delivery. By drawing on our professional liability closed claims data, we have identified common performance and diagnostic errors. We analyzed loss prevention measures in tandem with the elements necessary to conduct a credible and thorough root cause analysis to reduce system failures, respond to sentinel events, prevent medical errors, and improve patient safety. The purpose of this program is to provide clinicians with the most current information regarding the prevention of common performance and diagnostic errors. This course includes content specifically for Florida licensed practitioners.
December 05, 2024, Inside Medical Liability Online
Incidental Findings Can Lead to Malpractice Claims: Practice Protocols Can Help
If the ordering practitioner does not follow up, an incidental finding may lead to patient harm and result in a malpractice claim. The Doctors Company has completed a new analysis of medical malpractice claims against our members in which an incidental finding was identified as a contributing factor.
February 24, 2024, Risk Management and Healthcare Policy
Analysis of Closed Claims Among All Medical Specialties: Importance of Communication and Other Non-Clinical Contributing Factors
Evaluation of contributing factors associated with medical malpractice claims provides important information to optimize the patient–provider relationship. This review of closed claims from The Doctors Company highlights common factors contributing to lawsuits and strategies to avoid them, with a particular focus on communication.
Professional Education
Module 5: Eliminating Stigma Through Clinical Understanding of Substance Use Disorder (Innovations for Smart Approaches in Safe Prescribing)
You will explore how having a working awareness of neurobiology, psychology, and heritability of addiction positively impacts holistic treatment of opioid misuse. This module will examine how the etiology of stigma and how internalized biases impact the care of patients who misuse opioids. Lastly, this program will provide resources on how to connect to treatment for substance use disorder. This module consists of five audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
December 03, 2025, Physicians Practice
Top 7 Considerations for Telehealth in 2026
The clinical and regulatory landscape for telehealth continues to evolve rapidly. Medical and dental practices face a wide range of changing regulations, complicated payment issues, and growing patient safety risks. Julie Ritzman, MBA, CPHRM, Senior Vice President of Patient Safety and Risk Management at The Doctors Company, provides seven telehealth considerations for clinicians heading into 2026.
Patient Safety Strategies for Dermatology
Take steps to reduce risks in dermatology by reviewing your practices and systems and implementing these strategies.
January 29, 2025, ACS Practice Management
Lessons Learned from a Medical Malpractice Lawsuit: Aortic Surgery in a Patient with Significant Underlying Coronary Disease
David Han, MD, FACS, and Jacqueline Ross, RN, PhD, Coding Director, The Doctors Company, part of TDC Group, discuss the complications and critical decision-making errors in a case of aortic surgery on a patient with severe coronary disease. The article emphasizes the importance of thorough preoperative evaluation and considering all surgical options to manage complications effectively.
AM Best Affirms The Doctors Company’s ‘A’ Excellent Financial Rating
August 23, 2022: AM Best has affirmed The Doctors Company's financial strength rating (FSR) of A (Excellent) and its long-term issuer credit rating (ICR) of "a+”. The outlook of these ratings is stable.
Education for Advanced Practice Clinicians
We are proud to be the industry leader in providing essential patient safety resources and unparalleled options for contact hours and continuing education for advanced practice clinicians.
